Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 11, 2020

SELL
$1.3 - $2.72 $17,782 - $37,206
-13,679 Closed
0 $0
Q3 2019

Nov 07, 2019

SELL
$1.93 - $4.21 $3,599 - $7,851
-1,865 Reduced 12.0%
13,679 $32,000
Q2 2019

Jul 25, 2019

BUY
$2.05 - $4.32 $31,865 - $67,150
15,544 New
15,544 $67,000
Q1 2019

Apr 15, 2019

SELL
$1.79 - $3.12 $39,202 - $68,331
-21,901 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$2.24 - $3.9 $49,058 - $85,413
21,901 New
21,901 $56,000
Q2 2018

Aug 07, 2018

SELL
$4.43 - $5.14 $98,301 - $114,056
-22,190 Closed
0 $0
Q1 2018

May 04, 2018

BUY
$4.65 - $5.9 $103,183 - $130,921
22,190 New
22,190 $115,000
Q4 2017

Feb 01, 2018

SELL
$4.32 - $5.52 $86,771 - $110,874
-20,086 Closed
0 $0
Q3 2017

Oct 18, 2017

BUY
$4.35 - $5.25 $87,374 - $105,451
20,086
20,086 $105,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $78.9M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.